SEARCH RESULTS FOR: "Tag: NASDAQ-AIMT"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2018(1)
CATEGORIES
Buzz Stocks(1)

2/20/2018 10:25 AM
Aimmune Therapeutics Inc (NASDAQ:AIMT) stock is in focus this morning, after the company's peanut allergy drug AR101 met its late-stage study goals. Aimmune will now seek U.S. approval by the end of 2...
PEOPLE ALSO SEARCH FOR
 
Special Offers from Schaeffer's Trading Partners